ChoJHMukherjeeHSazhinV. Is antipsychotic augmentation associated with improved functioning in patients on clozapine?Australas Psychiatry2024; 32: 186–191.
2.
TaipaleHTanskanenATiihonenJ. Safety of antipsychotic polypharmacy versus monotherapy in a nationwide cohort of 61,889 patients with schizophrenia. Am J Psychiatr2023; 180: 377–385.
3.
TiihonenJTaipaleHMehtäläJ, et al.Association of antipsychotic polypharmacy vs monotherapy with psychiatric rehospitalization among adults with schizophrenia. JAMA Psychiatry2019; 76: 499–507.
